iShares Nasdaq Biotechnology Index Fund (IBB) ETF

Expense Ratio: 0.47% | AUM: 7.93B | Issuer: BlackRock

IBB Daily Price Range
IBB 52-Week Price Range

IBB - Real-Time SMART Grade™

B
Buy

Overall SMART Grade

IBB has a real-time SMART Grade of B (Buy).

Learn More About SMART Grades™

IBB - Profile & Info


The investment objective of the iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.

Issuer BlackRock
Expense Ratio 0.47%
Assets Under Management (AUM) 7.93B
Underlying Index NASDAQ Biotechnology Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Options? Yes
Total Holdings 167

IBB - Top Holdings

Symbol Holding Name % of Total
CELG Celgene Corp 8.84%
AMGN Amgen Inc 8.11%
GILD Gilead Sciences Inc 7.84%
REGN Regeneron Pharmaceuticals Inc 7.57%
BIIB Biogen Inc 6.56%
ALXN Alexion Pharmaceuticals Inc 5.12%
VRTX Vertex Pharmaceuticals Inc 4.27%
ILMN Illumina Inc 4.04%
INCY Incyte Corp 3.24%
BMRN BioMarin Pharmaceutical Inc 3.16%
MYL Mylan NV 2.85%
ENDP Endo International PLC 2.37%
SHPG Shire PLC 1.72%
JAZZ Jazz Pharmaceuticals PLC 1.54%
ALKS Alkermes PLC 1.50%
ALNY Alnylam Pharmaceuticals Inc 1.28%
MDVN Medivation Inc 1.08%
UTHR United Therapeutics Corp 1.07%
ISIS Isis Pharmaceuticals Inc 0.97%
QGEN QIAGEN NV 0.94%
ANAC Anacor Pharmaceuticals Inc 0.91%
SGEN Seattle Genetics Inc 0.78%
BLUE Bluebird Bio Inc 0.73%
HZNP Horizon Pharma Plc 0.70%
ICPT Intercept Pharmaceuticals Inc 0.69%
AKRX Akorn Inc 0.68%
RARE Ultragenyx Pharmaceutical Inc 0.65%
NBIX Neurocrine Biosciences Inc 0.64%
ACAD ACADIA Pharmaceuticals Inc 0.61%
TECH Bio-Techne Corp 0.53%
DYAX Dyax Corp 0.49%
CLVS Clovis Oncology Inc 0.49%
AGIO Agios Pharmaceuticals Inc 0.49%
IPXL Impax Laboratories Inc 0.45%
NVAX Novavax Inc 0.42%
MDCO Medicines Co 0.41%
MYGN Myriad Genetics Inc 0.41%
RDUS Radius Health Inc 0.41%
GRFS Grifols SA 0.38%
INSY Insys Therapeutics Inc 0.38%
PTLA Portola Pharmaceuticals Inc 0.36%
KITE Kite Pharma Inc 0.36%
CMRX Chimerix Inc 0.35%
HALO Halozyme Therapeutics Inc 0.33%
PCRX Pacira Pharmaceuticals Inc/DE 0.32%
KYTH KYTHERA Biopharmaceuticals Inc 0.30%
THRX Theravance Inc 0.29%
FOLD Amicus Therapeutics Inc 0.28%
LGND Ligand Pharmaceuticals Inc 0.27%
ALDR Alder Biopharmaceuticals Inc 0.27%
PRTA Prothena Corp PLC 0.26%
DEPO Depomed Inc 0.25%
MNKD MannKind Corp 0.24%
TTPH Tetraphase Pharmaceuticals Inc 0.24%
SAGE Sage Therapeutics Inc 0.24%
GWPH GW Pharmaceuticals PLC 0.23%
ARIA ARIAD Pharmaceuticals Inc 0.23%
OPHT Ophthotech Corp 0.23%
NKTR Nektar Therapeutics 0.23%
INSM Insmed Inc 0.23%
CEMP Cempra Inc 0.22%
SRPT Sarepta Therapeutics Inc 0.21%
CLDX Celldex Therapeutics Inc 0.21%
IRWD Ironwood Pharmaceuticals Inc 0.21%
ZSPH ZS Pharma Inc 0.21%
ACOR Acorda Therapeutics Inc 0.21%
PTCT PTC Therapeutics Inc 0.20%
NLNK NewLink Genetics Corp 0.20%
LXRX Lexicon Pharmaceuticals Inc 0.19%
MNTA Momenta Pharmaceuticals Inc 0.19%
EXEL Exelixis Inc 0.19%
AMAG AMAG Pharmaceuticals Inc 0.18%
IMGN ImmunoGen Inc 0.17%
SCMP Sucampo Pharmaceuticals Inc 0.17%
RGEN Repligen Corp 0.17%
MACK Merrimack Pharmaceuticals Inc 0.17%
ACHN Achillion Pharmaceuticals Inc 0.16%
RPTP Raptor Pharmaceutical Corp 0.16%
ZFGN Zafgen Inc 0.15%
RLYP Relypsa Inc 0.15%
XLRN Acceleron Pharma Inc 0.14%
SUPN Supernus Pharmaceuticals Inc 0.14%
RTRX Retrophin Inc 0.14%
FLML Flamel Technologies SA 0.13%
MGNX MacroGenics Inc 0.13%
PDLI PDL BioPharma Inc 0.13%
BCRX BioCryst Pharmaceuticals Inc 0.13%
GHDX Genomic Health Inc 0.12%
EPZM Epizyme Inc 0.12%
FMI Foundation Medicine Inc 0.12%
ARRY Array BioPharma Inc 0.12%
LMNX Luminex Corp 0.12%
SGYP Synergy Pharmaceuticals Inc 0.12%
ENTA Enanta Pharmaceuticals Inc 0.11%
RVNC Revance Therapeutics Inc 0.11%
AFFX Affymetrix Inc 0.11%
AMRI Albany Molecular Research Inc 0.10%
ARNA Arena Pharmaceuticals Inc 0.10%
OSIR Osiris Therapeutics Inc 0.10%
SGNT Sagent Pharmaceuticals Inc 0.09%
PETX Aratana Therapeutics Inc 0.09%
AMPH Amphastar Pharmaceuticals Inc 0.09%
ANIP ANI Pharmaceuticals Inc 0.09%
OMED OncoMed Pharmaceuticals Inc 0.08%
GERN Geron Corp 0.08%
INO Inovio Pharmaceuticals Inc 0.08%
CARA Cara Therapeutics Inc 0.08%
VNDA Vanda Pharmaceuticals Inc 0.08%
AEGR Aegerion Pharmaceuticals Inc 0.08%
CERS Cerus Corp 0.07%
KPTI Karyopharm Therapeutics Inc 0.07%
FPRX Five Prime Therapeutics Inc 0.07%
OMER Omeros Corp 0.07%
PGNX Progenics Pharmaceuticals Inc 0.07%
TBPH Theravance Biopharma Inc 0.07%
SGMO Sangamo BioSciences Inc 0.07%
RGLS Regulus Therapeutics Inc 0.06%
XNPT XenoPort Inc 0.06%
INFI Infinity Pharmaceuticals Inc 0.06%
SPPI Spectrum Pharmaceuticals Inc 0.06%
AERI Aerie Pharmaceuticals Inc 0.06%
SCLN SciClone Pharmaceuticals Inc 0.06%
PACB Pacific Biosciences of California Inc 0.05%
USD CASH 0.05%
CNCE Concert Pharmaceuticals Inc 0.05%
VSAR Versartis Inc 0.05%
OREX Orexigen Therapeutics Inc 0.05%
SVA Sinovac Biotech Ltd 0.04%
POZN POZEN Inc 0.04%
SNTA Synta Pharmaceuticals Corp 0.04%
PTX Pernix Therapeutics Holdings Inc 0.04%
CCXI ChemoCentryx Inc 0.04%
AAVL Avalanche Biotechnologies Inc 0.04%
CGEN Compugen Ltd 0.04%
SQNM Sequenom Inc 0.03%
VSTM Verastem Inc 0.03%
ECYT Endocyte Inc 0.03%
AKBA Akebia Therapeutics Inc 0.03%
IMMU Immunomedics Inc 0.03%
ACRX AcelRx Pharmaceuticals Inc 0.03%
QLTI QLT Inc 0.02%
ALIM Alimera Sciences Inc 0.02%
VVUS VIVUS Inc 0.02%
XOMA XOMA Corp 0.01%
CLDN Celladon Corp 0.00%

IBB - News


View All IBB News

IBB - Price/Volume Stats

Current price $273.42
Prev. close $274.48
Day low $272.66
Day high $276.45
52-week high $301.80
52-week low $240.03
Day Volume 1,163,136
Avg. volume 1,787,223
Dividend yield 0.18%

IBB - Recent Returns

1-mo 2.52%
3-mo 2.15%
6-mo -3.07%
1-year -4.89%
3-year 8.17%
5-year 145.64%
YTD 3.03%
2016 -21.42%
2015 11.56%
2014 33.83%
2013 65.54%
2012 32.13%

IBB - Stock Chart


IBB - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
Page generated in 2.1744 seconds.